Biose Industrie, a French contract development and manufacturing organization that focuses on live biotherapeutic products, has raised 30 million euros in funding. Cathay Capital led the round.
CAMBRIDGE, UK , July 09, 2024 (GLOBE NEWSWIRE) -- Microbiotica, a biopharma company developing a pipeline of orally-delivered precision microbiome medicines called live biotherapeutic products (LBPs), ...
Maxence Desjonquères (far left), CEO of Biose, meets with Massachusetts life sciences and economic development leaders in the Massachusetts Pavilion at the BIO 2016 Convention in San Francisco, ...
REHOVOT, Israel, Jan. 14, 2020 /PRNewswire/ -- Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results